Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Wai Chun Bio-Technology Ltd. ( (HK:0660) ).
Wai Chun Bio-Technology Limited has announced a delay in the dispatch of a circular related to a connected transaction involving the issuance of new convertible bonds under a specific mandate. The circular, which includes important information for shareholders such as recommendations from the Independent Board Committee and details of the new convertible bonds, was initially expected by August 15, 2025, but will now be dispatched by August 25, 2025, due to the need for additional time to finalize certain information.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Limited is a company incorporated in the Cayman Islands, operating within the biotechnology industry. The company focuses on developing and providing innovative biotechnology solutions, although specific products or services are not detailed in the announcement.
Average Trading Volume: 274,197
Technical Sentiment Signal: Hold
Current Market Cap: HK$42.66M
Learn more about 0660 stock on TipRanks’ Stock Analysis page.